Dialysis and Contrast Media
Extracellular water soluble contrast media, whether gadolinium- or iodine-based, can be removed from the circulation by hemodialysis and less efficiently by peritoneal dialysis. Hemodialysis has no role in prevention of contrast-induced nephropathy and patients on hemodialysis do not need to receive dialysis shortly after administration of iodine-based contrast media. The administration of low stability gadolinium-based contrast media to patients receiving dialysis has been associated with development of nephrogenic systemic fibrosis. Only highly stable gadolinium-based contrast agents at the smallest possible dose should be used if contrast enhanced MR is considered essential in patients receiving dialysis. Patients already on hemodialysis should undergo a hemodialysis session as soon as practically possible after administration of gadolinium-based contrast agents.
KeywordsContrast Medium Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Nephrogenic Systemic Fibrosis Dialysis Fluid
- Morcos SK, Thomsen HS, Webb JAW and members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (1999) Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613Google Scholar
- Morcos SK, Thomsen HS, Webb JAW and members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2002) Dialysis and contrast media. Eur Radiol 12:3026–3030Google Scholar